Defence Therapeutics Inc.
DTC
Kedudukan dalam Saham
#29780
Headquartered in Vancouver, Canada, Defence Therapeutics Inc. is a... Headquartered in Vancouver, Canada, Defence Therapeutics Inc. is a biotechnology company founded in 2017. This firm focuses on pioneering biological and biosimilar therapeutic solutions for both cancer and infectious diseases. A cornerstone of its approach is the exclusive ACCUM™ technology, engineered to precisely and safely transport vaccine antigens or antibody-drug conjugates (ADCs) directly to their intended cellular targets. The company's development efforts span several key areas: novel dendritic cell vaccines for various cancers, protein-based vaccines addressing COVID-19 and other infectious ailments, and specialized antibody-drug conjugate products aimed at different cancer types. Defence Therapeutics Inc. adopted its current name in March 2020, having previously operated as Accum Therapeutics Inc.
Harga Saham
$0.24953854
Disegerakkan terakhir: 2026-10-16
Modal Pasaran
$18.91M
Perubahan (1 hari)
-5.56%
Perubahan (1 tahun)
-53.23%
Negara
CA
Perdagangan Defence Therapeutics Inc. (DTC)
Kategori
Healthcare
Modal pasaran bagi Defence Therapeutics Inc.(DTC)
Modal Pasaran: $18.91M
Sehingga October 2026, Defence Therapeutics Inc. mempunyai modal pasaran sebanyak $18.91M. Ini menjadikan Defence Therapeutics Inc. syarikat ke-29780th paling bernilai di dunia mengikut data kami. Kapitalisasi pasaran ialah nilai keseluruhan saham syarikat tersenarai yang berada dalam edaran dan lazimnya digunakan untuk menilai nilai syarikat tersebut.
Sejarah modal pasaran Defence Therapeutics Inc. dari 2021 hingga 2026
DTC berbanding dengan 5 teratas yang paling popular stocks
